BI
ACAD icon

Binnacle Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Binnacle Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$405 Buy
+19
New +$449 ﹤0.01% 873
2025
Q2 		– Sell
-19
Closed -$316 – 774
2025
Q1 		$316 Buy
+19
New +$345 ﹤0.01% 748

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Binnacle Investments's ACAD Position: Q3 2025 in Review

Binnacle Investments opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2025: 19 shares worth $405. The stake represents ﹤0.01% of the portfolio and ranks #873 among its holdings. This is a return to the name: Binnacle Investments previously reported a position in ACAD as recently as Q1 2025.

Binnacle Investments first reported a position in ACAD in Q1 2025 and has held it in 2 quarters since. 333 funds tracked by Wall St. Rank hold ACAD as of Q3 2025.

  • Binnacle Investments held 19 shares of Acadia Pharmaceuticals worth $405 as of Q3 2025.
  • Acadia Pharmaceuticals was a new Binnacle Investments position in Q3 2025.
  • Acadia Pharmaceuticals made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #873 holding.
  • Binnacle Investments first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 333 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.